Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Winograd

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Research|April 1, 1986
Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogueB Winograd, J B Vermorken, W W ten Bokkel Huinink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignanciesG Schwartsmann, P Dodion, J B Vermorken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcomaP S Gill, A Tulpule, B M Espina, et al.
Seminars in Oncology|August 1, 1995
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trialJ B Vermorken, W W ten Bokkel Huinink, I A Mandjes, et al.
British Journal of Cancer|October 1, 1987
Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trialF Elferink, W J van der Vijgh, W W ten Bokkel Huinink, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics and toxicology of sparsomycin in beagle dogsZ Zylicz, D J Wagener, P Fernandez del Moral, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Research|April 1, 1986
Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogueB Winograd, J B Vermorken, W W ten Bokkel Huinink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignanciesG Schwartsmann, P Dodion, J B Vermorken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcomaP S Gill, A Tulpule, B M Espina, et al.
Seminars in Oncology|August 1, 1995
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trialJ B Vermorken, W W ten Bokkel Huinink, I A Mandjes, et al.
British Journal of Cancer|October 1, 1987
Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trialF Elferink, W J van der Vijgh, W W ten Bokkel Huinink, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics and toxicology of sparsomycin in beagle dogsZ Zylicz, D J Wagener, P Fernandez del Moral, et al.
Pageof 4